✦ LIBER ✦

Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation

✍ Scribed by Türkeri, L N; Ayaz, O; Özyürek, M; Akdas, A

Book ID: 110073164
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 43 KB
Volume: 2
Category: Article
ISSN: 1365-7852
DOI: 10.1038/sj.pcan.4500358

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results from a pilot Phase I trial of ge

Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer

✍ George Wilding; Patrick Soulie; Donald Trump; Ashis Das-Gupta; Eric Small 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

308 IMPACT OF PSA FLARE-UP UNDER THE COM

308 IMPACT OF PSA FLARE-UP UNDER THE COMBINED TREATMENT WITH DOCETAXEL AND ESTRAMUSTINE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER

✍ T. Nelius; T. Klatte; W. De Riese; S. Filleur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Zoledronic acid in combination with seri

Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A

✍ Yalcin Cirak; Umut Varol; Harika Atmaca; Asli Kisim; Canfeza Sezgin; Bulent Kara 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

EVALUATION OF OUTCOMES AND GENETIC PREDI

EVALUATION OF OUTCOMES AND GENETIC PREDICTIVE FACTORS FOR PROGNOSIS AND TOXICITY IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS FOLLOWING COMBINATION THERAPY WITH DOCETAXEL, ESTRAMUSTINE, AND CARBOPLATIN

✍ Narita, Shintaro; Tsuruta, Hiroshi; Saito, Mitsuru; Kumazawa, Teruaki; Horikawa, 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 46 KB

Weekly administration of docetaxel in co

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study

✍ Carles, J; Font, A; Mellado, B; Domenech, M; Gallardo, E; González-Larriba, J L; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Early results of a multicenter phase 2 s

Early results of a multicenter phase 2 study: Weekly docetaxel and intermittent estramustin as combination chemotherapy in patients with hormone-refractory prostate cancer (HRPC)

✍ U. Steiner; K. Miller; S. Machtens; B. Backhaus; M. Siegsmund 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 226 KB